Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04727307
Title Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial (AB-LATE02)
Acronym AB-LATE02
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital, Montpellier
Age Groups: senior | adult
Covered Countries FRA

No variant requirements are available.